A Safe and Effective Non-Opioid Pain Management Solution
Sancuso – the Difference Between Life and Living
Cumberland to highlight 2025 financial, international, portfolio and clinical progress
NASHVILLE, Tenn. , Feb. 25, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused on developing new products for rare diseases, today...
The full sales and operational launch of Talicia, under the joint commercialization agreement between Talicia Holdings Inc. (THI), a jointly controlled entity of RedHill and Cumberland has started and...
NASHVILLE, Tenn. , Feb. 24, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company, announced today that it will release its 2025 financial results...
NASHVILLE, Tenn. , Feb. 4, 2026 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) , a specialty pharmaceutical company focused on developing new products for rare diseases, announced...
NASHVILLE, Tenn. , Dec. 8, 2025 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX), today announced an important update regarding its Caldolor ® (ibuprofen) Injection. The product's...